Vanguard Group’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
|
|||||
2022
Q4 | $30.7K | Hold |
|
|||||
2022
Q3 | $49K | Sell |
|
|||||
2022
Q2 | $111K | Hold |
|
|||||
2022
Q1 | $122K | Sell |
|
|||||
2021
Q4 | $960K | Sell |
|
|||||
2021
Q3 | $984K | Buy |
|
|||||
2021
Q2 | $533K | Buy |
|
|||||
2021
Q1 | $357K | Buy |
|
|||||
2020
Q4 | $181K | Hold |
|
|||||
2020
Q3 | $104K | Hold |
|
|||||
2020
Q2 | $135K | Hold |
|
|||||
2020
Q1 | $88K | Buy |
|
|||||
2019
Q4 | $21K | Sell |
|
|||||
2019
Q3 | $54K | Buy |
|
|||||
2019
Q2 | $77K | Sell |
|
|||||
2019
Q1 | $176K | Hold |
|
|||||
2018
Q4 | $108K | Sell |
|
|||||
2018
Q3 | $342K | Hold |
|
|||||
2018
Q2 | $419K | Hold |
|
|||||
2018
Q1 | $514K | Buy |
|
|||||
2017
Q4 | $631K | Sell |
|
|||||
2017
Q3 | $586K | Hold |
|
|||||
2017
Q2 | $501K | Buy |
|
|||||
2017
Q1 | $132K | Hold |
|
|||||
2016
Q4 | $117K | Hold |
|
|||||
2016
Q3 | $143K | Sell |
|
|||||
2016
Q2 | $248K | Hold |
|
|||||
2016
Q1 | $223K | Buy |
|
|||||
2015
Q4 | $306K | Sell |
|
|||||
2015
Q3 | $385K | Buy |
|
|||||
2015
Q2 | $361K | Buy |
|
|||||
2015
Q1 | $295K | Buy |
|
|||||
2014
Q4 | $402K | Sell |
|
|||||
2014
Q3 | $662K | Buy |
|
|||||
2014
Q2 | $674K | Buy |
|
|||||
2014
Q1 | $933K | Buy |
|
|||||
2013
Q4 | $1.57M | Hold |
|
|||||
2013
Q3 | $2.1M | Buy |
|
|||||
2013
Q2 | $2.12M | Buy |
|